Unexpected cardiotoxicity in haematological bortezomib treated patients

被引：155
|
作者：
Orciuolo, Enrico [1 ]
Buda, Gabriele
Cecconi, Nadia
Galimberti, Sara
Versari, Daniele
Cervetti, Giulia
Salvetti, Antonio
Petrini, Mario
机构：
[1] Univ Pisa, Dept Oncol Transplant & Adv Med, Sect Haematol, I-56100 Pisa, Italy
[2] Univ Pisa, Dept Internal Med, I-56100 Pisa, Italy
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2007年 / 138卷 / 03期
关键词：
bortezomib; cardiotoxicity; haematological patients;
D O I：
10.1111/j.1365-2141.2007.06659.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：396 / 397
页数：2
相关论文
共 50 条
  • [1] Identifying early suboptimal haematological response in patients with AL amyloidosis treated with bortezomib-based chemotherapy
    Mollee, Peter
    Gibbons, Anthea
    Anderson, Niri Ranjit
    Korczyk, Dariusz
    Gibbs, Simon
    Sidiqi, Hasib
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S282 - S283
  • [2] Cardiotoxicity in patients treated with acalabrutinib
    Langerbeins, Petra
    BLOOD, 2022, 140 (20) : 2096 - 2097
  • [3] Cardiotoxicity in patients treated with anthracyclines
    Santoro, M
    Santoro, A
    Maiorino, L
    BALKAN CONGRESS OF ONCOLOGY, 1996, : 55 - 57
  • [4] Unexpected Cardiotoxicity in Patients With HER2-Mutant NSCLC Treated With Trastuzumab Deruxtecan: A Case Report
    Riudavets, Mariona
    Azarine, Arshid
    Smaali, Sondes
    Kim, Young-Wouk
    Montpreville, Vincent Thomas de
    Grecea, Alina Miruna
    Naltet, Charles
    Gazzah, Annas
    Planchard, David
    JTO CLINICAL AND RESEARCH REPORTS, 2022, 3 (12):
  • [5] Cardiotoxicity of the Anticancer Therapeutic Agent Bortezomib
    Nowis, Dominika
    Maczewski, Michal
    Mackiewicz, Urszula
    Kujawa, Marek
    Ratajska, Anna
    Wieckowski, Mariusz R.
    Wilczynski, Grzegorz M.
    Malinowska, Monika
    Bil, Jacek
    Salwa, Pawel
    Bugajski, Marek
    Wojcik, Cezary
    Sinski, Maciej
    Abramczyk, Piotr
    Winiarska, Magdalena
    Dabrowska-Iwanicka, Anna
    Duszyniski, Jerzy
    Jakobisiak, Marek
    Golab, Jakub
    AMERICAN JOURNAL OF PATHOLOGY, 2010, 176 (06): : 2658 - 2668
  • [6] MANAGEMENT OF HAEMATOLOGICAL PATIENTS TREATED WITH CARDIOTOXIC DRUGS
    Dolenc, Jure
    Kozelj, Mirta
    Zver, Samo
    ZDRAVNISKI VESTNIK-SLOVENIAN MEDICAL JOURNAL, 2008, 77 : I19 - I24
  • [7] INCIDENCE OF NEUROPATHY IN PATIENTS TREATED WITH SUBCUTANEOUS BORTEZOMIB
    Vicent Castello, A.
    Pellise Guinjoan, A.
    Escoda Teigell, L.
    Casanova Molla, J.
    Pascual Rubio, V
    Talarn Forcadell, C.
    Do Nascimento, J.
    Vallansot, R.
    Aguinaco Culebras, R.
    Gimenez Perez, T.
    Araguas Arasanz, C.
    Bru Orobal, N.
    Esteban Figuerola, A.
    Sarra Escarre, J.
    HAEMATOLOGICA, 2015, 100 : 113 - 114
  • [8] Neuropathic pain in cancer patients treated with bortezomib
    Exposito Vizcaino, S.
    Casanova-Molla, J.
    Escoda, L.
    Galan, S.
    Miro, J.
    NEUROLOGIA, 2018, 33 (01): : 28 - 34
  • [9] Cardiotoxicity in Patients Treated With Bevacizumab Is Potentially Reversible
    Hawkes, Eliza A.
    Okines, Alicia F. C.
    Plummer, Chris
    Cunningham, David
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (18) : E560 - E562
  • [10] Late Cardiotoxicity in MS Patients Treated with Mitoxantrone
    Najafian, Jamshid
    Nasri, Ali
    Etemadifar, Masoud
    Salehzadeh, Fardin
    INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE, 2019, 10
12345